In this Rare Mind Talks episode, I sit down with Richard Novak, CEO of Unravel Biosciences, to explore how RNA provides real-time insight into the body’s actions, while DNA remains static. With the motto of treating the patient, not the disease, this shift in approach changes how we understand rare diseases. This special episode was recorded live at the ZTTK Foundation Conference in Boston, capturing the energy of families, researchers, and advocates. Richard explains why every patient's journey is unique. He shows how Unravel uses AI and data to identify subgroups, predict responses, and repurpose drugs. The focus shifts from treating diseases to treating patients. We also discuss the role of patient advocates, global data collection, and breaking barriers in research. Finally, we reflect on trust, transparency, and learning from failure. This conversation is about redefining healthcare with patients at the centre. Rare Mind Talks podcast explores how AI, data, and innovation are transforming healthcare for rare diseases. Hosted by André Correia, a digital transformation leader and rare disease advocate, this Podcast aims to simplify complex topics, inspire research, and connect experts to improve lives. Learn more at https://www.theraremind.com or Follow us on Instagram @theraremindtalks